... опубликованных во второй половине 2017 г.
, MD, Prof.,
Kuban State Medical University of the Ministry of Health of Russia, Krasnodar
Search for an optimal efficacy-to-safety ratio for anti-platelet therapy of ischemic heart disease
Acetylsalicylic acid remains the basis of anti-platelet therapy for stable ischemic heart disease (IHD), including conditino after coronary artery bypass grafting. Double anti-platelet therapy (APT) consisting of acetylsalicylic acid and a P2Y12 receptor ...